BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2628072)

  • 21. In vitro assays for antitumour activity: more pitfalls to come?
    Hanauske AR
    Eur J Cancer; 1993; 29A(11):1502-3. PubMed ID: 8217351
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing.
    Keepers YP; Pizao PE; Peters GJ; van Ark-Otte J; Winograd B; Pinedo HM
    Eur J Cancer; 1991; 27(7):897-900. PubMed ID: 1834124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal conditions of chemotherapeutic sensitivity in K562 cell line using tetrazolium dye assay.
    Yu D; Yu LL
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):137-40. PubMed ID: 8352006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemosensitivity testing with highly purified fresh human tumour cells with the MTT colorimetric assay.
    Yamaue H; Tanimura H; Tsunoda T; Tani M; Iwahashi M; Noguchi K; Tamai M; Hotta T; Arii K
    Eur J Cancer; 1991; 27(10):1258-63. PubMed ID: 1835595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
    Osawa Y; Yoshida A; Asaga T; Kawahara S; Yanoma S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):471-6. PubMed ID: 8678500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the anti-proliferative activity of styrylazanaphthalenes and azanaphthalenediones.
    Mrozek-Wilczkiewicz A; Kalinowski DS; Musiol R; Finster J; Szurko A; Serafin K; Knas M; Kamalapuram SK; Kovacevic Z; Jampilek J; Ratuszna A; Rzeszowska-Wolny J; Richardson DR; Polanski J
    Bioorg Med Chem; 2010 Apr; 18(7):2664-71. PubMed ID: 20303768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer.
    Xu JM; Song ST; Tang ZM; Liu XQ; Jiang ZF; Zhou L; Li YB; Huang Y
    Breast Cancer Res Treat; 1998 Jun; 49(3):251-9. PubMed ID: 9776509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tetrazolium-based colorimetric assay (MTT) and its application in chemosensitivity testing of antitumor Chinese medicine].
    Wu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1992 Nov; 27(6):373-5. PubMed ID: 1307965
    [No Abstract]   [Full Text] [Related]  

  • 31. [Standard deviation of inhibition index of chemosensitivity testing using the MTT assay].
    Hamajima N; Yamauchi M; Kato K; Takagi H; Kondo T; Inokuchi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):249-51. PubMed ID: 1736838
    [No Abstract]   [Full Text] [Related]  

  • 32. High-throughput screening platform for anticancer therapeutic drug cytotoxicity.
    Sekhon BK; Roubin RH; Tan A; Chan WK; Sze DM
    Assay Drug Dev Technol; 2008 Oct; 6(5):711-21. PubMed ID: 19035851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro chemosensitivity test for human genitourinary tumors using collagen gel matrix.
    Uchibayashi T; Egawa M; Hisazumi H; Hasegawa T; Tanaka T; Sasaki T
    Eur Urol; 1993; 24(2):267-70. PubMed ID: 7690707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A trial of isolation in chemotherapy for gynecological malignant tumor by MTT assay].
    Sato Y; Igarashi S; Higuchi J; Soga K; Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1421-4. PubMed ID: 8270830
    [No Abstract]   [Full Text] [Related]  

  • 35. Histoculture drug response assay to monitor chemoresponse.
    Ohie S; Udagawa Y; Aoki D; Nozawa S
    Methods Mol Med; 2005; 110():79-86. PubMed ID: 15901929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro assays to predict drug sensitivity and drug resistance. A panel discussion.
    McGuire WL; Kern DH; Von Hoff DD; Weisenthal LM
    Breast Cancer Res Treat; 1988 Sep; 12(1):7-21. PubMed ID: 3196887
    [No Abstract]   [Full Text] [Related]  

  • 37. [Significance of cancer cell purification determining chemosensitivities for gastric cancer cells].
    Morishita T; Kato M; Nakamura T; Saitoh Y
    Nihon Geka Gakkai Zasshi; 1995 Jul; 96(7):448-55. PubMed ID: 7675024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitivity testing predicts survival in ovarian cancer.
    Taylor CG; Sargent JM; Elgie AW; Williamson CJ; Lewandowicz GM; Chappatte O; Hill JG
    Eur J Gynaecol Oncol; 2001; 22(4):278-82. PubMed ID: 11695809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients.
    Dhar S; Gullbo J; Csoka K; Eriksson E; Nilsson K; Nickel P; Larsson R; Nygren P
    Eur J Cancer; 2000 Apr; 36(6):803-9. PubMed ID: 10762755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.